Scott Barrier

Senior Director Head CNS Neurology Gene Therapy Programs

Role
Senior Director Head Cns Neurology Gene Therapy Programs at Sarepta Therapeutics
Location
Cambridge, MA, US
LinkedIn followers
500 followers
Research & DevelopmentView LinkedIn profile

About Scott Barrier

Very experienced Senior Leader with a demonstrated history of working in the Rare…

Experience

  1. Senior Director Head Cns Neurology Gene Therapy Programs

    Sarepta Therapeutics

    Jul 2015 — Present

    Sarepta Therapeutics: a commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics and Gene Therapy for the treatment of rare neuromuscular diseases. Our primary focus is on rapidly advancing the development of our potentially disease-modifying Duchenne muscular dystrophy (DMD) drug candidates employing our RNA and Gene Therapy program candidates.

Education

  • Commonwealth University-Bloomsburg

    BA

    1974 — 1978

Skills

  • Nephrology
  • Cardiology
  • Genetics
  • Sales
  • Infectious Diseases
  • Pharmaceutical Sales
  • Marketing
  • Commercialization
  • Sales Effectiveness
  • Life Sciences
  • Rheumatology
  • Product Launch
  • Endocrinology
  • Medical Devices
  • Cross-Functional Team Leadership
  • Biotechnology
  • Pharmaceutical Industry
  • Urology

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Scott Barrier — Senior Director Head Cns Neurology Gene Therapy Programs at Sarepta Therapeutics in Cambridge, MA, US | Unifers